ArticleInternational journal of retina and vitreous2025
High-resolution optical coherence tomography in pigmented choroidal lesions.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Macular Layer Thickness with Spectral-Domain and High-Resolution OCT.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEvaluating High-Resolution Optical Coherence Tomography (HR-OCT) versus standard spectral domain OCT in pigmented choroidal lesions.
methodsWe screened a total of 40 subjects with pigmented choroidal lesions. Lesions were imaged on HR-OCT and standard OCT devices with and without enhanced depth imaging (EDI) mode. Images were graded for qualitative and quantitative aspects, like choriocapillaris compression and width, choroidal reflectivity and thickness, amongst others.
results32 of the 40 subjects could be included in the image analysis, the rest were excluded due to insufficient imaging. HR-OCT EDI mode allowed visualization of the posterior choroidal extent in 11 lesions (11/32 = 34.4%) versus in six (6/32; 18.8%), four (4/30; 13.3%), and five cases (5/30; 16.7%) in normal HR-OCT (n = 32), standard OCT (n = 30) and OCT EDI mode (n = 30), respectively, albeit not significantly different. Choriocapillaris compression was evident in 10 cases on HR-OCT and equally visible in all imaging modes. Mean choriocapillaris thickness ranged from 11.6 to 13.9 microns (SD range 3.84-4.33), and compressed choriocapillaris thickness similarly ranged from a mean of 7.1 to 7.8 microns (SD range 2.20-3.55). Image quality declined significantly towards the periphery in three out of four modes (p = 0.0077 to p = 0.29).
conclusionsHR-OCT may provide better visibility of retinal and choroidal structures in pigmented choroidal lesions, although image quality is reduced in attempting to image peripheral lesions. TRANSLATIONAL RELEVANCE: The prototype HR-OCT offers insights into clinical features of pigmented choroidal lesions that are not apparent on conventional OCT imaging. This supports the development of HR-OCTolution OCT devices.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.